BioArctic AB Stock
BioArctic AB Stock price
Key metrics
| Market capitalization | SEK17.32b |
| Enterprise Value | SEK16.89b |
| P/E (TTM) P/E ratio | negative |
| EV/Sales (TTM) EV/Sales | 56.43 |
| P/S ratio (TTM) P/S ratio | 57.86 |
| P/B ratio (TTM) P/B ratio | 18.70 |
| Revenue growth (TTM) Revenue growth | -72.47% |
| Revenue (TTM) Revenue | SEK167.14m |
| EBIT (operating result TTM) EBIT | SEK-255.90m |
Is BioArctic AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
BioArctic AB Stock Analysis
Analyst Opinions
6 Analysts have issued a BioArctic AB forecast:
Analyst Opinions
6 Analysts have issued a BioArctic AB forecast:
Financial data from BioArctic AB
| Sep '24 |
+/-
%
|
||
| Revenue | 167 167 |
72%
72%
|
|
| Gross Profit | 95 95 |
73%
73%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -256 -256 |
192%
192%
|
| Net Profit | -233 -233 |
190%
190%
|
|
In millions SEK.
Don't miss a Thing! We will send you all news about BioArctic AB directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden.
| Head office | Sweden |
| CEO | Gunilla Osswald |
| Employees | 88 |
| Founded | 2000 |
| Website | www.bioarctic.se |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
